ID: ALA2262382

Max Phase: Preclinical

Molecular Formula: C20H15ClN4O4S

Molecular Weight: 442.88

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1ccc2nc(Cl)c(/C=N/NC(=O)C3=C(O)c4ccccc4S(=O)(=O)N3)cc2c1

Standard InChI:  InChI=1S/C20H15ClN4O4S/c1-11-6-7-15-12(8-11)9-13(19(21)23-15)10-22-24-20(27)17-18(26)14-4-2-3-5-16(14)30(28,29)25-17/h2-10,25-26H,1H3,(H,24,27)/b22-10+

Standard InChI Key:  QRWVBGJOQIYICE-LSHDLFTRSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 442.88

Molecular Weight (Monoisotopic): 442.0503

AlogP: 2.87

#Rotatable Bonds: 3

Polar Surface Area: 120.75

Molecular Species: ACID

HBA: 6

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 4.87

CX Basic pKa: 0.16

CX LogP: 2.78

CX LogD: 0.35

Aromatic Rings: 3

Heavy Atoms: 30

QED Weighted: 0.33

Np Likeness Score: -1.44

References

1. Ahmad M, Rizvi SUF, Siddiqui HL, Ahmad S, Parvez M, Suliman R.  (2012)  Antioxidant and antimicrobial studies of novel N-(substituted-2-chloroquinolin-3-yl)methylidene-4-hydroxy-2H-1,2-benzothiazine-3-carbohydrazides 1,1-dioxides,  21  (9): [10.1007/s00044-011-9755-5]

Source

Source(1):

• Scientific Literature